Clinical Outcome and Prognostic Factors of Sorafenib in Japanese Patients with Advanced Renal Cell Carcinoma in General Clinical Practice

Objective Effects of sorafenib in general clinical practice, especially those with patients of Asian ethnicity, have been rarely investigated. We assessed efficacy, safety and prognostic factors for progression-free survival in Japanese patients receiving sorafenib for advanced renal cell carcinoma....

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Japanese journal of clinical oncology 2011-11, Vol.41 (11), p.1265-1270
Hauptverfasser:	Tanigawa, Go, Kawashima, Atsunari, Yamaguchi, Seiji, Nishimura, Kazuo, Miyoshi, Susumu, Kajikawa, Jiro, Meguro, Norio, Yosioka, Toshiaki, Oka, Toshitsugu, Hara, Tsuneo, Takayama, Hitoshi, Nonomura, Norio
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Antineoplastic Agents - therapeutic use Asian Continental Ancestry Group Benzenesulfonates - therapeutic use Carcinoma, Renal Cell - drug therapy Carcinoma, Renal Cell - secondary Cohort Studies Female Follow-Up Studies Humans Kidney Neoplasms - drug therapy Kidney Neoplasms - pathology Male Maximum Tolerated Dose Middle Aged Neoplasm Metastasis Neoplasm Staging Niacinamide - analogs & derivatives Phenylurea Compounds Practice Patterns, Physicians Prognosis Pyridines - therapeutic use Retrospective Studies Survival Rate
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!